Skip to main content
. 2017 Jul 27;7:6676. doi: 10.1038/s41598-017-06011-7

Figure 2.

Figure 2

Increased frequencies and expression of Hobit on CD56bright liver NK cells. (a) Histogram (left panel) showing Hobit expression on bulk NK cells in the blood (dark grey), the liver (light grey) and a FMO control (white). Contour plots showing the expression of Hobit on CD56dim (blue) and CD56bright (red) NK cells in the blood and liver. (b) Frequency (left panel) of Hobitpos bulk, CD56dim,CD56bright CD16+ and CD56bright CD16- NK cells in the blood (open symbols) and liver (yellow symbols). Ratio of the frequency (right panel) of Hobitpos cells in each subset between liver and peripheral blood. (c) Expression (left panel) of Hobit on bulk, CD56dim, CD56bright CD16+ and CD56bright CD16- NK cells in the blood (open symbols) and liver (yellow symbols). Ratio of the expression (right panel) of Hobit in each subset between liver and peripheral blood samples. Individual data points are blotted in the graphs on the left side. Box and whiskers (Tukey) was used to depict the expression ratio between liver and blood. Wilcoxon matched pair sign rank test was used to determine statistical differences in the scatter plots and Friedman test was used for box plots.